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uTo the Editor: After coronary stent placement, the vascular re-
sponse to injury includes re-endothelialization by resident and
circulating bone marrow–derived endothelial progenitor cells (1).
Delayed re-endothelialization after drug-eluting stent (DES) im-
plantation may lead to uncovered stent struts and an increased risk
for stent thrombosis. Telomeres are tandem repeat deoxyribonu-
cleic acid sequences (TTAGGG)n that form protective caps at the
nds of all eukaryotic chromosomes and undergo obligate short-
ning during mitosis (2). Once a critical degree of telomere
hortening has occurred, cells may become senescent or undergo
poptosis. Leukocyte telomere length (LTL) can be measured to
ssess the degree of telomere shortening in bone marrow–derived
ells and has recently emerged as a predictor of subsequent
ardiovascular risk (3).
Optical coherence tomography (OCT) is a near-infrared tech-
ology that can image coronary arteries with exquisite resolution,
llowing direct visualization of neointimal healing and stent strut
overage after percutaneous coronary intervention (4). We hypothe-
ized that shorter LTL, as a marker of bone marrow senescence,
ould be associated with less neointimal stent strut coverage after
ercutaneous coronary intervention. The goal of this study was
herefore to assess the relationship between LTL and cross-
ectional measurements on OCT of stent strut coverage.
Twenty-three subjects with prior DES implantation underwent
uantitative angiography, OCT, and LTL measurements per-
ormed 6 months after index percutaneous coronary intervention.
trut-level and cross-sectional measurements were made at 1-mm
ntervals at a core laboratory by investigators blinded to clinical
nformation. An uncovered stent strut was defined as a strut with
o definite (10 m) neointima. The percent of uncovered stent
struts was determined by dividing the total number of uncovered
stent struts by the total number of stent struts and multiplying by
100. Neointimal thickness was also measured in each cross-section,
and mean neointimal thickness was averaged over the stented
region. Blood samples were obtained at the time of OCT, and
genomic deoxyribonucleic acid was isolated from the buffy coat.
Relative LTL was then measured by quantitative polymerase chain
reaction comparing the mean telomere repeat sequence copy
numbers (T) with a reference single copy human gene, beta-globin
(S). LTL is reported as T/S, as previously described (5).
Continuous variables are presented as median (interquartile
range [IQR]) and categorical variables as percents or counts.
Because telomere length was not normally distributed, all analyses
were performed using log-transformed data. We assessed the
association between LTL and measures of stent strut coverage
using Pearson’s correlation coefficient. All analyses were performed
using Stata version 11.2 (StataCorp LP, College Station, Texas).
All authors had full access to the data, and the institutional reviewboards of the participating institutions approved this study. Writ-
ten informed consent was obtained from all subjects before study
participation.
All 23 subjects underwent stent implantation for acute coronary
syndromes. The median age at stent implantation was 57 years
(IQR: 50 to 68 years). Fourteen patients (61%) were men, 10
(44%) had histories of diabetes, 8 (34%) were active smokers, and
all patients were prescribed statin medications after the procedure.
The target vessel was the left anterior descending coronary artery
in 17, the right coronary artery in 5, and the circumflex coronary
artery in 1. Eighteen patients (78%) had sirolimus-eluting stents
placed, and 5 (22%) had paclitaxel-eluting stents placed. The
median stent length was 28 mm (IQR: 18 to 33 mm), and the
median stent diameter was 3.0 mm (IQR: 2.75 to 3.5 mm).
Eighteen patients (78%) had post-dilation performed at the time
of initial stent implantation.
The mean time from stent implantation to follow-up angiog-
raphy and OCT was 6.0  0.2 months. By quantitative angiog-
raphy, the percent diameter restenosis was 17% (IQR: 14% to
20%). The median percent of uncovered stent struts visualized by
cross-sectional OCT was 11% (IQR: 1.7% to 20%), the percent
cross-section of the stented region with uncovered struts was 8.6%
(IQR: 3.2% to 28.6%), and the mean neointimal thickness was 97 m
IQR: 56 to 188 m). There was no evidence of intracoronary
hrombus by OCT. These results were unchanged when the
nalysis was restricted to only subjects who had sirolimus-eluting
tents placed.
LTL was inversely associated with the percent cross-section of
ncovered struts (R2  0.47, p  0.03) and percent stent strut
coverage (R2  0.48, p  0.02) (Fig. 1). There was also a
nonsignificant trend between LTL and mean neointimal coverage
(R2  0.28, p  0.20). Because LTL is inversely correlated with
age, we also examined the association of LTL and stent strut
coverage, adjusted for age. After age adjustment, every 1-U
increase in log LTL T/S was associated with an 8% decrease in the
percent of uncovered stent struts (p  0.02).
The main finding of this study is that LTL is inversely associated
with stent strut coverage after percutaneous coronary intervention
with DES. Shorter LTL may be a marker of functional exhaustion of
the endothelial progenitor cell compartment, which results in blunted
endothelial cell proliferative capacity. An impaired proliferative re-
sponse after stent placement may predispose to uncovered stent struts
and possibly increased risk for stent thrombosis. LTL may therefore
be a useful biomarker to predict neointimal coverage after DES
placement independent of the patient’s chronological age. Future
prospective studies that incorporate other variables affecting stent strut
coverage should investigate use of this marker to predict target-vessel
outcomes after DES implantation.
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Figure 1 Association of Telomere Length With Uncovered Stent Struts
(A) Uncovered stent struts were identified by cross-sectional analysis of optical co
quantitative polymerase chain reaction. There was an inverse correlation between
patient with short LTL (T/S  0.94), 28% of all stent struts were uncovered. Arrow
2.3) had 1% uncovered stent struts (arrows show struts covered by neointima).doi:10.1016/j.jacc.2012.03.028lease note: Dr. Shunk has received grant support from Siemens Medical Systems,
bbott Vascular, and InfraReDx. Dr. Jang has received research grant support and
onsulting fees from LightLab Imaging/St. Jude Medical. All other authors have
eported that they have no relationships relevant to the contents of this paper to
isclose.
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